Viatris (VTRS) Shares Outstanding (2019 - 2026)

Viatris' (VTRS) quarterly Shares Outstanding (Entity) came in at $1.2 billion in Q2 2021, little changed quarter-over-quarter from $1.2 billion in Q1 2021.

Viatris (VTRS) Shares Outstanding (2019 - 2026) Analysis & Trends

Viatris' Shares Outstanding (Entity) history runs 2 years deep, the most recent figure standing at $1.2 billion for Q2 2021.

  • On a quarterly basis, Shares Outstanding (Entity) changed N/A year-over-year to $1.2 billion in Q2 2021; TTM through Jun 2021 was $1.2 billion, a N/A change from a year earlier, with the FY2018 full-year figure at $514.5 million, changed N/A from the prior year.
  • Shares Outstanding (Entity) steadied at $1.2 billion in Q2 2021 per VTRS's latest filing, from $1.2 billion in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $1.2 billion in Q2 2021 and bottomed at $516.4 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.16 Bn
Dec 31, 2025 1.17 Bn
Sep 30, 2025 1.16 Bn
Jun 30, 2025 1.17 Bn
Mar 31, 2025 1.19 Bn
Dec 31, 2024 1.19 Bn
Sep 30, 2024 1.19 Bn
Jun 30, 2024 1.19 Bn
Mar 31, 2024 1.20 Bn
Dec 31, 2023 1.20 Bn
Sep 30, 2023 1.20 Bn
Jun 30, 2023 1.20 Bn
Mar 31, 2023 1.20 Bn
Dec 31, 2022 1.21 Bn
Sep 30, 2022 1.21 Bn
Jun 30, 2022 1.21 Bn
Mar 31, 2022 1.21 Bn
Dec 31, 2021 1.21 Bn
Sep 30, 2021 1.21 Bn
Jun 30, 2021 1.21 Bn